Inflammatory bowel disease, or IBD, is estimated to impact more than 2 million Americans. This term encompasses different disorders relating to inflammation in the digestive tract, such as ulcerative colitis and Crohn’s disease. And up until now, traditional gastroenterology took a linear view of treatment options, ignoring the impacts of diet and lifestyle, while many patients continued to struggle.

Today’s guest on The Doctor’s Farmacy, Dr. Miguel Regueiro, is part of the positive shift happening in the conventional approach to IBD. Dr. Regueiro is the chair of Cleveland Clinic’s Department of Gastroenterology and Hepatology; his main clinical and research interest is IBD, with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. This innovative healthcare delivery system has defined the concept of specialty medical home and will lead to further clinical programs and investigation of alternative models of care.

EPA projections show Ireland off track for 2030 climate targets